nani treatment for Inteshar Al-shar (male pattern hair loss)

Phase 2

• Conditions: Health Condition 1: - Health Condition 2: L648- Other androgenic alopecia

• Registration Number: CTRI/2020/04/024474
• Lead Sponsor: ational Institute of Unani Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Male Patients with age between 20-50 years

2. Patient with mild to moderately severe male pattern hair loss according to Norwood-Hamilton classification scale Type II to VI (Excluding Type IIa, IIIa and III vertex)

3. Patients who will give consent and able to do follow up

Exclusion Criteria

1. Male patients below 20 and above 50 years

2. Patients with Seborrheic dermatitis, Lichen planopilaris, Scalp psoriasis, Tinea Capitis, Alopecia areata, Trichotillomania and Scarring alopecia

3. Patients suffering from systemic illnesses like HTN, DM, Malignancy, Liver or Kidney dysfunction

4. Patients had received either CAM therapy or anti-androgenic medications or drugs causing hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, penicillamine, streptomycin and cortisone) or hypotrichosis (anti-coagulants, retinoids, lithium and beta blockers), use of finasteride or other 5-α reductase inhibitors or topical minoxidil within 01 month prior to enrolment

5. Patients with surgical correction of scalp hair loss (hair transplant or scalp reduction)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Patient Self-Assessment <br/ ><br>2. Trichoscopy <br/ ><br>3. Investigator assessment using PhotographyTimepoint: 60 days

Secondary Outcome Measures

Name	Time	Method
1.Improvement in Quality of Life by using Hair specific Skindex-29Timepoint: 60 days